Encapsulating peritoneal sclerosis in children. (Q38164559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

1 March 2020

title

Encapsulating peritoneal sclerosis in children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

1 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

Constantinos J Stefanidis

1 March 2020

series ordinal

1

object named as

Constantinos J Stefanidis

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

1 March 2020

30 August 2017

publication date

21 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

1 March 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

1 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

2093-2103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Sclerosing peritonitis without reduced ultrafiltration as complication of peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Post-transplantation encapsulating peritoneal sclerosis in a young child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Encapsulating peritoneal sclerosis: clinical significance and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Encapsulating peritoneal sclerosis in the new millennium: a national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Old and new perspectives on peritoneal dialysis in Italy emerging from the Peritoneal Dialysis Study Group Census

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

The role of peritoneal alternatively activated macrophages in the process of peritoneal fibrosis related to peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Experimental diabetes induces functional and structural changes in the peritoneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Risk Factors Associated with Encapsulating Peritoneal Sclerosis in Dutch Eps Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Effects of icodextrin on the peritoneal membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Corticosteroid therapy in encapsulating peritoneal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Differential Effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Early quality of life benefits of icodextrin in peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-013-2672-8

Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children

21 January 2018

1 reference

12 December 2020

Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study

1 reference

12 December 2020

Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis

1 reference

12 December 2020

Different aspects of peritoneal damage: fibrosis and sclerosis

1 reference

12 December 2020

Unusual small intestinal obstruction in adolescent girls: the abdominal cocoon

1 reference

12 December 2020

Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature

1 reference

12 December 2020

Chronic abdominal pain in a patient on chronic peritoneal dialysis: question

1 reference

12 December 2020

The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis

1 reference

12 December 2020

Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients

1 reference

12 December 2020

Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone.

1 reference

12 December 2020

Experimental encapsulating peritoneal sclerosis models: pathogenesis and treatment.

1 reference

12 December 2020

Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells.

1 reference

12 December 2020

Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.

1 reference

12 December 2020

Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures.

1 reference

12 December 2020

Post-transplantation encapsulating peritoneal sclerosis in a pediatric patient

1 reference

12 December 2020

The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells.

1 reference

12 December 2020

Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis

1 reference

12 December 2020

Sclerosing encapsulating peritonitis in children.

1 reference

12 December 2020

Encapsulating peritoneal sclerosis in a peritoneal dialysis patient using biocompatible fluids only: is Alport syndrome a risk factor?

1 reference

12 December 2020

Seventeen years' experience of surgical options for encapsulating peritoneal sclerosis

1 reference

12 December 2020

Case-control study to determine the cause of sclerosing peritoneal disease

1 reference

12 December 2020

Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis

1 reference

12 December 2020

Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions

1 reference

12 December 2020

Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production

1 reference

12 December 2020

Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model

1 reference

12 December 2020

Use of Angiotensin II Inhibitors in Patients that Develop Encapsulating Peritoneal Sclerosis

1 reference

12 December 2020

Factors contributing to peritoneal tissue remodeling in peritoneal dialysis.

1 reference

12 December 2020

Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function?

1 reference

12 December 2020

Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment

1 reference

12 December 2020

Sclerosing encapsulating peritonitis

1 reference

12 December 2020

Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol)

1 reference

12 December 2020

No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis

1 reference

12 December 2020

Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment

1 reference

12 December 2020

The natural course of peritoneal membrane biology during peritoneal dialysis.

1 reference

12 December 2020

Peritoneal accumulation of AGE and peritoneal membrane permeability

1 reference

12 December 2020

Pathology of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone

1 reference

12 December 2020

Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences

1 reference

12 December 2020

Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients

1 reference

12 December 2020

High incidence of encapsulating peritoneal sclerosis in pediatric patients on peritoneal dialysis longer than 10 years

1 reference

12 December 2020

Role of acetate in loss of ultrafiltration during CAPD.

1 reference

12 December 2020

Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment

1 reference

12 December 2020

Screening for encapsulating peritoneal sclerosis in patients on peritoneal dialysis: role of CT scanning

1 reference

12 December 2020

Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation

1 reference

12 December 2020

10.1007/S00467-013-2672-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 March 2020

1020870082

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24258273 AND SRC:MED&resulttype=core&format=json